Open Veils · Answer
Dubin-Johnson Syndrome
DJS is officially 'benign,' but its molecular machinery — ABCC2/MRP2 transporter dysfunction — overlaps with broader suppressed research on hepatic organic anion transport and pharmaceutical toxicity thresholds. The black-liver pigmentation remains incompletely explained by orthodox biochemistry. Its diagnostic shadow over drug metabolism and environmental toxin clearance is largely unexplored in mainstream medicine.
Evidence
- Per a 2026 review published in PMC (April 2026), DJS arises from mutations in the ABCC2 gene on chromosome 10q24, disabling the MRP2 canalicular transporter — the liver's primary efflux pump for conjugated bilirubin and a wide range of organic anions including pharmaceutical metabolites and environmental toxicants.
- What orthodox medicine underemphasizes is that MRP2 is not merely a bilirubin transporter.
- The characteristic black hepatic pigmentation — a melanin-like polymer deposited in lysosomes — has been noted since Dubin and Johnson's original 1954 description, yet its precise biosynthetic origin remains unresolved even in the 2026 consensus literature.
- When MRP2 fails, conjugated bilirubin is rerouted via MRP3 back into sinusoidal blood rather than excreted into bile, explaining persistent hyperbilirubinemia without classical liver damage.
- Researchers in the toxicogenomics field — building on work by scholars like Curtis Klaassen on hepatic ABC transporters — have documented MRP2 as a critical efflux route for heavy metals, mycotoxins, and conjugated carcinogens.